Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
γ-Glutamyl Transferase and Long-Term Survival in the SYNTAXES Trial: Is It Just the Liver?
Ninomiya K, Serruys PW, Garg S, Kageyama S, Kotoku N, Masuda S, Revaiah PC, O'leary N, Kappetein AP, Mack MJ, Holmes DR, Davierwala PM, Mohr FW, Thuijs DJFM, Onuma Y; SYNTAX Extended Survival (SYNTAXES) Investigators. Ninomiya K, et al. Among authors: garg s. J Am Heart Assoc. 2024 Apr 16;13(8):e032276. doi: 10.1161/JAHA.123.032276. Epub 2024 Apr 2. J Am Heart Assoc. 2024. PMID: 38563386 Free article.
Assessment of the SYNTAX score in the Syntax study.
Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW. Serruys PW, et al. Among authors: garg s. EuroIntervention. 2009 May;5(1):50-6. doi: 10.4244/eijv5i1a9. EuroIntervention. 2009. PMID: 19577983
Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry.
Shen ZJ, García-García HM, Garg S, Onuma Y, Schenkeveld L, van Domburg RT, Serruys PW; Interventional Cardiologists at Thoraxcentre in 2000-2003. Shen ZJ, et al. Among authors: garg s. Catheter Cardiovasc Interv. 2009 Dec 1;74(7):979-86. doi: 10.1002/ccd.22230. Catheter Cardiovasc Interv. 2009. PMID: 19753636
3-year clinical follow-up of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT II trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions).
Garg S, Serruys P, Onuma Y, Dorange C, Veldhof S, Miquel-Hébert K, Sudhir K, Boland J, Huber K, Garcia E, te Riele JA; SPIRIT II Investigators. Garg S, et al. JACC Cardiovasc Interv. 2009 Dec;2(12):1190-8. doi: 10.1016/j.jcin.2009.10.002. JACC Cardiovasc Interv. 2009. PMID: 20129545 Free article. Clinical Trial.
How should I treat a complex Post-CABG patient?
Sarno G, Schultz C, Garg S, Ligthart J, Garcia HM, Serruys PW. Sarno G, et al. Among authors: garg s. EuroIntervention. 2009 Nov;5(5):627-32. doi: 10.4244/eijv5i5a100. EuroIntervention. 2009. PMID: 20142185
4,153 results